Skip to main content
SpringerLink
Log in

Gentamicin as gene therapy

  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Luft FC, Kleit SA (1974) Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis 130:656–659

    Article  CAS  PubMed  Google Scholar 

  2. Luft FC, Patel V, Yum MN, Patel B, Kleit SA (1975) Experimental aminoglycoside nephrotoxicity. J Lab Clin Med 86:213–220

    CAS  PubMed  Google Scholar 

  3. Silverblatt FJ, Kuehn C (1979) Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int 15:335–345

    Article  CAS  PubMed  Google Scholar 

  4. Schmitz C, Hilpert J, Jacobsen C, Boensch C, Christensen EI, Luft FC, Willnow TE (2002) Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem 277:618–622

    Article  CAS  PubMed  Google Scholar 

  5. Stephens D, Garey N, Isles A, Levison H, Gold R (1983) Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis. Pediatr Infect Dis 2:209–211

    Article  CAS  PubMed  Google Scholar 

  6. McCracken GH Jr (1986) Aminoglycoside toxicity in infants and children. Am J Med 80:172–178

    Article  PubMed  Google Scholar 

  7. Hamilton JW (2001) Gentamicin in pharmacogenetic approach to treatment of cystic fibrosis. Lancet 358:2014–2016

    Article  CAS  PubMed  Google Scholar 

  8. Howard M, Frizzell RA, Bedwell DM (1996) Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 2:467–469

    Article  CAS  PubMed  Google Scholar 

  9. Bedwell DM, Kaenjak A, Benos DJ, Bebok Z, Bubien JK, Hong J, Tousson A, Clancy JP, Sorscher EJ (1997) Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med 3:1280–1284

    Article  CAS  PubMed  Google Scholar 

  10. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375–381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Clancy JP, Bebok Z, Ruiz F, King C, Jones J, Walker L, Greer H, Hong J, Wing L, Macaluso M, Lyrene R, Sorscher EJ, Bedwell DM (2001) Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 163:1683–1692

    Article  CAS  PubMed  Google Scholar 

  12. Du M, Jones JR, Lanier J, Keeling KM, Lindsey JR, Tousson A, Bebök Z, Whitsett JA, Dey CR, Colledge WH, Evans MJ, Sorscher EJ, Bedwell DM (2002) Aminoglycoside suppression of a premature stop mutation in a Cftr–/–mouse carrying a human CFTR-G542X transgene. J Mol Med (http://dx.doi.org/10.1007/s00109-002-0363-1)

    Google Scholar 

  13. Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF (2000) Sequence specificity of aminoglycoside- induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48:164–169

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Franz-Volhard-Klinik, Humboldt University of Berlin, Wiltbergstrasse 50, 13125, Berlin-Buch, Germany

    F. C. Luft

Authors
  1. F. C. Luft
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luft, F.C. Gentamicin as gene therapy. J Mol Med 80, 543–544 (2002). https://doi.org/10.1007/s00109-002-0367-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-002-0367-x

Keywords

Search

Navigation